Skip to main content

Hepatology Topic Center

Featured Article

News
04/15/2025
Jessica Garlewicz
The findings underscore the substantial burden of steatotic liver disease and highlight the importance of recognizing its distinct subtypes in clinical practice.
The findings underscore the substantial burden of steatotic liver disease and highlight the importance of recognizing its distinct subtypes in clinical practice.
The findings underscore the...
04/15/2025
Gastroenterology
News
04/03/2025
Jessica Garlewicz
The study synthesizes data from 18 studies and more than half a million subjects to better characterize how nonbiologic factors contribute to MASLD burden.
The study synthesizes data from 18 studies and more than half a million subjects to better characterize how nonbiologic factors contribute to MASLD burden.
The study synthesizes data from...
04/03/2025
Gastroenterology
News
04/03/2025
Jessica Garlewicz
A new study examined 792,409 hospitalizations for Crohn's disease, of which 26,229 (3.3%) involved patients with coexisting metabolic dysfunction-associated steatotic liver disease.
A new study examined 792,409 hospitalizations for Crohn's disease, of which 26,229 (3.3%) involved patients with coexisting metabolic dysfunction-associated steatotic liver disease.
A new study examined 792,409...
04/03/2025
Gastroenterology
News
04/01/2025
Jessica Garlewicz
For practicing gastroenterologists, these results highlight the importance of proactive risk assessment and coordinated care strategies in MASLD populations, beyond liver-specific endpoints.
For practicing gastroenterologists, these results highlight the importance of proactive risk assessment and coordinated care strategies in MASLD populations, beyond liver-specific endpoints.
For practicing...
04/01/2025
Gastroenterology
News
04/01/2025
Jessica Garlewicz
The study analyzed data from the Research Patient Data Registry between 2000 and 2023, focusing on patients aged 40 and older with a baseline FIB-4 score of 1.3 or higher.
The study analyzed data from the Research Patient Data Registry between 2000 and 2023, focusing on patients aged 40 and older with a baseline FIB-4 score of 1.3 or higher.
The study analyzed data from the...
04/01/2025
Gastroenterology
News
03/25/2025
Jessica Garlewicz
Findings of a recent study highlight the potential utility of routine imaging-based screening for liver disease in at-risk populations.
Findings of a recent study highlight the potential utility of routine imaging-based screening for liver disease in at-risk populations.
Findings of a recent study...
03/25/2025
Gastroenterology
News
03/17/2025
Jessica Garlewicz
MRI improves early diagnosis of hepatocellular carcinoma among patients with cirrhosis compared to ultrasonography.
MRI improves early diagnosis of hepatocellular carcinoma among patients with cirrhosis compared to ultrasonography.
MRI improves early diagnosis of...
03/17/2025
Gastroenterology
News
03/14/2025
Jessica Garlewicz
LiverPRO provides an efficient and evidence-based approach to improving early detection and management of liver disease in primary care settings.
LiverPRO provides an efficient and evidence-based approach to improving early detection and management of liver disease in primary care settings.
LiverPRO provides an efficient...
03/14/2025
Gastroenterology
News
03/14/2025
Jessica Garlewicz
Systematic screening for liver disease in overweight and obese patients may be warranted, researchers conclude.
Systematic screening for liver disease in overweight and obese patients may be warranted, researchers conclude.
Systematic screening for liver...
03/14/2025
Gastroenterology
News
03/14/2025
Jessica Garlewicz
MASLD will increasingly drive rates of hepatocellular carcinoma, liver transplant, and liver-related mortality, according to a new study.
MASLD will increasingly drive rates of hepatocellular carcinoma, liver transplant, and liver-related mortality, according to a new study.
MASLD will increasingly drive...
03/14/2025
Gastroenterology
News
03/14/2025
Jessica Garlewicz
A risk-based approach offers clinicians a practical method to evaluate MASLD, prioritize fibrosis regression, and address the interconnected metabolic conditions contributing to patient outcomes.
A risk-based approach offers clinicians a practical method to evaluate MASLD, prioritize fibrosis regression, and address the interconnected metabolic conditions contributing to patient outcomes.
A risk-based approach offers...
03/14/2025
Gastroenterology

Videos

Blanca Lizaolo-Mayo
Video
11/15/2024
Blanca Lizaolo-Mayo, MD
Dr Lizaolo-Mayo discusses factors to consider when diagnosing and treating patients without obesity or overweight who may have metabolic-associated steatohepatitis (MASH).
Dr Lizaolo-Mayo discusses factors to consider when diagnosing and treating patients without obesity or overweight who may have metabolic-associated steatohepatitis (MASH).
Dr Lizaolo-Mayo discusses...
11/15/2024
Gastroenterology
Video
06/14/2024
Kayla Monks, MS, RD, discusses nutritional needs and challenges of patients with liver disease, including candidates for transplant, and how to work with patients to achieve the best possible outcomes.
Kayla Monks, MS, RD, discusses nutritional needs and challenges of patients with liver disease, including candidates for transplant, and how to work with patients to achieve the best possible outcomes.
Kayla Monks, MS, RD, discusses...
06/14/2024
Gastroenterology
Lauren Yang, MD, on Hepatitis B Research
Videos
12/01/2020
In this video, Lauren Yang, MD, from Beth Israel Deaconess Medical Center, discusses what learned at the recent American Association for the Study of Liver Diseases annual meeting about research into managing hepatitis B.
In this video, Lauren Yang, MD, from Beth Israel Deaconess Medical Center, discusses what learned at the recent American Association for the Study of Liver Diseases annual meeting about research into managing hepatitis B.
In this video, Lauren Yang, MD,...
12/01/2020
Gastroenterology
Video
02/20/2025
Alan Bonder, MD; Gordon Jiang, MD; Hirsh Trivedi, MD
In part 2 of this video roundtable on NASH and MASLD, Drs Alan Bonder, Gordon Jiang, and Hirsh Trivedi discuss the staging of these conditions and lifestyle changes that patients can make to improve outcomes.
In part 2 of this video roundtable on NASH and MASLD, Drs Alan Bonder, Gordon Jiang, and Hirsh Trivedi discuss the staging of these conditions and lifestyle changes that patients can make to improve outcomes.
In part 2 of this video...
02/20/2025
Gastroenterology
Video
01/23/2025
Alan Bonder, MD; Hirsh Trivedi, MD; Gordon Jiang, MD
Alan Bonder, MD, Hirsh Trivedi, MD, and Gordon Jiang, MD, discuss the importance of identifying features of metabolic syndrome when assessing patients for potential metabolic dysfunction-associated liver disease--and starting the process at...
Alan Bonder, MD, Hirsh Trivedi, MD, and Gordon Jiang, MD, discuss the importance of identifying features of metabolic syndrome when assessing patients for potential metabolic dysfunction-associated liver disease--and starting the process at...
Alan Bonder, MD, Hirsh Trivedi,...
01/23/2025
Gastroenterology
Amy Oxentenko
Video
01/02/2025
Amy Oxentenko, MD
Dr Oxentenko gives a look into the future for the treatment of celiac disease, including the potential of therapies to offer alternatives to the gluten-free diet.
Dr Oxentenko gives a look into the future for the treatment of celiac disease, including the potential of therapies to offer alternatives to the gluten-free diet.
Dr Oxentenko gives a look into...
01/02/2025
Gastroenterology
Aasma Shaukat
Conference Coverage
12/04/2024
Aasma Shaukat, MD
Dr Shaukat reviews new alternatives for noninvasive colon cancer screening, including 2 stool-based and 1 blood-based test. 
Dr Shaukat reviews new alternatives for noninvasive colon cancer screening, including 2 stool-based and 1 blood-based test. 
Dr Shaukat reviews new...
12/04/2024
Gastroenterology
Aasma Shaukat
Conference Coverage
11/22/2024
Aasma Shaukat, MD
Dr Shaukat discusses risk stratification for colorectal cancer screening and surveillance for low- and high-risk patients. 
Dr Shaukat discusses risk stratification for colorectal cancer screening and surveillance for low- and high-risk patients. 
Dr Shaukat discusses risk...
11/22/2024
Gastroenterology
Blanca Lizaolo-Mayo
Video
11/21/2024
Blanca Lizaolo-Mayo, MD
Blanca Lizaolo-Mayo, MD, reviews the importance of considering metabolic risk factors even among patients without obesity or overweight to detect metabolic dysfunction-related steatohepatitis.
Blanca Lizaolo-Mayo, MD, reviews the importance of considering metabolic risk factors even among patients without obesity or overweight to detect metabolic dysfunction-related steatohepatitis.
Blanca Lizaolo-Mayo, MD, reviews...
11/21/2024
Gastroenterology
Hirsh Trivedi
Video
11/20/2024
Hirsh Trivedi, MD
Dr Hirsh Trivedi details how he approaches the diagnosis and management of metabolic-dysfunction associated fatty liver disease (MAFLD, formerly NAFLD) and metabolic associated steatohepatosis (MASH, formerly NASH.)
Dr Hirsh Trivedi details how he approaches the diagnosis and management of metabolic-dysfunction associated fatty liver disease (MAFLD, formerly NAFLD) and metabolic associated steatohepatosis (MASH, formerly NASH.)
Dr Hirsh Trivedi details how he...
11/20/2024
Gastroenterology
Blanca Lizaolo-Mayo
Video
11/15/2024
Blanca Lizaolo-Mayo, MD
Dr Lizaolo-Mayo discusses factors to consider when diagnosing and treating patients without obesity or overweight who may have metabolic-associated steatohepatitis (MASH).
Dr Lizaolo-Mayo discusses factors to consider when diagnosing and treating patients without obesity or overweight who may have metabolic-associated steatohepatitis (MASH).
Dr Lizaolo-Mayo discusses...
11/15/2024
Gastroenterology
Evan Dellon
Conference Coverage
10/28/2024
Evan S. Dellon, MD
Dr Dellon, from the University of North Carolina, reviews a recent update to guidelines for eosinophilic esophagitis.
Dr Dellon, from the University of North Carolina, reviews a recent update to guidelines for eosinophilic esophagitis.
Dr Dellon, from the University...
10/28/2024
Gastroenterology
Bill Chey
Videos
07/30/2024
William D. Chey, MD
Dr Chey reviews his presentation on the role of diet in disorders of gut-brain interaction from Digestive Disease Week 2024.
Dr Chey reviews his presentation on the role of diet in disorders of gut-brain interaction from Digestive Disease Week 2024.
Dr Chey reviews his presentation...
07/30/2024
Gastroenterology

News

News
04/15/2025
Jessica Garlewicz
The findings underscore the substantial burden of steatotic liver disease and highlight the importance of recognizing its distinct subtypes in clinical practice.
The findings underscore the substantial burden of steatotic liver disease and highlight the importance of recognizing its distinct subtypes in clinical practice.
The findings underscore the...
04/15/2025
Gastroenterology
News
04/03/2025
Jessica Garlewicz
The study synthesizes data from 18 studies and more than half a million subjects to better characterize how nonbiologic factors contribute to MASLD burden.
The study synthesizes data from 18 studies and more than half a million subjects to better characterize how nonbiologic factors contribute to MASLD burden.
The study synthesizes data from...
04/03/2025
Gastroenterology
News
04/03/2025
Jessica Garlewicz
A new study examined 792,409 hospitalizations for Crohn's disease, of which 26,229 (3.3%) involved patients with coexisting metabolic dysfunction-associated steatotic liver disease.
A new study examined 792,409 hospitalizations for Crohn's disease, of which 26,229 (3.3%) involved patients with coexisting metabolic dysfunction-associated steatotic liver disease.
A new study examined 792,409...
04/03/2025
Gastroenterology
News
04/01/2025
Jessica Garlewicz
For practicing gastroenterologists, these results highlight the importance of proactive risk assessment and coordinated care strategies in MASLD populations, beyond liver-specific endpoints.
For practicing gastroenterologists, these results highlight the importance of proactive risk assessment and coordinated care strategies in MASLD populations, beyond liver-specific endpoints.
For practicing...
04/01/2025
Gastroenterology
News
04/01/2025
Jessica Garlewicz
The study analyzed data from the Research Patient Data Registry between 2000 and 2023, focusing on patients aged 40 and older with a baseline FIB-4 score of 1.3 or higher.
The study analyzed data from the Research Patient Data Registry between 2000 and 2023, focusing on patients aged 40 and older with a baseline FIB-4 score of 1.3 or higher.
The study analyzed data from the...
04/01/2025
Gastroenterology
News
03/25/2025
Jessica Garlewicz
Findings of a recent study highlight the potential utility of routine imaging-based screening for liver disease in at-risk populations.
Findings of a recent study highlight the potential utility of routine imaging-based screening for liver disease in at-risk populations.
Findings of a recent study...
03/25/2025
Gastroenterology
News
03/17/2025
Jessica Garlewicz
MRI improves early diagnosis of hepatocellular carcinoma among patients with cirrhosis compared to ultrasonography.
MRI improves early diagnosis of hepatocellular carcinoma among patients with cirrhosis compared to ultrasonography.
MRI improves early diagnosis of...
03/17/2025
Gastroenterology
News
03/14/2025
Jessica Garlewicz
LiverPRO provides an efficient and evidence-based approach to improving early detection and management of liver disease in primary care settings.
LiverPRO provides an efficient and evidence-based approach to improving early detection and management of liver disease in primary care settings.
LiverPRO provides an efficient...
03/14/2025
Gastroenterology
News
03/14/2025
Jessica Garlewicz
Systematic screening for liver disease in overweight and obese patients may be warranted, researchers conclude.
Systematic screening for liver disease in overweight and obese patients may be warranted, researchers conclude.
Systematic screening for liver...
03/14/2025
Gastroenterology
News
03/14/2025
Jessica Garlewicz
MASLD will increasingly drive rates of hepatocellular carcinoma, liver transplant, and liver-related mortality, according to a new study.
MASLD will increasingly drive rates of hepatocellular carcinoma, liver transplant, and liver-related mortality, according to a new study.
MASLD will increasingly drive...
03/14/2025
Gastroenterology
News
04/17/2025
Jessica Garlewicz
The findings underscore an urgent need for integrated care approaches involving gastroenterologists and addiction specialists.
The findings underscore an urgent need for integrated care approaches involving gastroenterologists and addiction specialists.
The findings underscore an...
04/17/2025
Gastroenterology
News
04/15/2025
Jessica Garlewicz
Clinicians may need to consider routine assessments for esophageal malignancy and respiratory complications as part of a long-term care strategy.
Clinicians may need to consider routine assessments for esophageal malignancy and respiratory complications as part of a long-term care strategy.
Clinicians may need to consider...
04/15/2025
Gastroenterology
News
04/15/2025
Jessica Garlewicz
The findings underscore the substantial burden of steatotic liver disease and highlight the importance of recognizing its distinct subtypes in clinical practice.
The findings underscore the substantial burden of steatotic liver disease and highlight the importance of recognizing its distinct subtypes in clinical practice.
The findings underscore the...
04/15/2025
Gastroenterology
News
04/03/2025
Jessica Garlewicz
The study synthesizes data from 18 studies and more than half a million subjects to better characterize how nonbiologic factors contribute to MASLD burden.
The study synthesizes data from 18 studies and more than half a million subjects to better characterize how nonbiologic factors contribute to MASLD burden.
The study synthesizes data from...
04/03/2025
Gastroenterology
News
04/03/2025
Jessica Garlewicz
A new study examined 792,409 hospitalizations for Crohn's disease, of which 26,229 (3.3%) involved patients with coexisting metabolic dysfunction-associated steatotic liver disease.
A new study examined 792,409 hospitalizations for Crohn's disease, of which 26,229 (3.3%) involved patients with coexisting metabolic dysfunction-associated steatotic liver disease.
A new study examined 792,409...
04/03/2025
Gastroenterology
News
04/02/2025
Jessica Garlewicz
A new update from the US Multi-Society Task Force on Colorectal Cancer revises and refines recommendations for optimizing bowel preparation in colonoscopy.
A new update from the US Multi-Society Task Force on Colorectal Cancer revises and refines recommendations for optimizing bowel preparation in colonoscopy.
A new update from the US...
04/02/2025
Gastroenterology
News
04/01/2025
Jessica Garlewicz
For practicing gastroenterologists, these results highlight the importance of proactive risk assessment and coordinated care strategies in MASLD populations, beyond liver-specific endpoints.
For practicing gastroenterologists, these results highlight the importance of proactive risk assessment and coordinated care strategies in MASLD populations, beyond liver-specific endpoints.
For practicing...
04/01/2025
Gastroenterology
News
04/01/2025
Jessica Garlewicz
The study analyzed data from the Research Patient Data Registry between 2000 and 2023, focusing on patients aged 40 and older with a baseline FIB-4 score of 1.3 or higher.
The study analyzed data from the Research Patient Data Registry between 2000 and 2023, focusing on patients aged 40 and older with a baseline FIB-4 score of 1.3 or higher.
The study analyzed data from the...
04/01/2025
Gastroenterology
News
04/01/2025
Jessica Garlewicz
A newly developed clinical prediction model offers a tool to estimate the likelihood of advanced colorectal neoplasia among younger adults.
A newly developed clinical prediction model offers a tool to estimate the likelihood of advanced colorectal neoplasia among younger adults.
A newly developed clinical...
04/01/2025
Gastroenterology
News
04/01/2025
Jessica Garlewicz
The TEMPO trial enrolled 40,000 adults aged 50–74 years and randomly assigned them to one of eight groups, testing combinations of a planning tool and deadline prompts of varying lengths.
The TEMPO trial enrolled 40,000 adults aged 50–74 years and randomly assigned them to one of eight groups, testing combinations of a planning tool and deadline prompts of varying lengths.
The TEMPO trial enrolled 40,000...
04/01/2025
Gastroenterology